Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Another French market introduction for Lescol

Nov. 22, 1996

Alkermes and Genentech expand collaboration for sustained-release human GH

Nov. 22, 1996

New impotence treatment deemed approvable by FDA

Nov. 22, 1996

Antidiabetic agents reported by Terumo

Nov. 22, 1996

First regulatory approval for impotence treatment

Nov. 21, 1996

Thrombopoietic activity of PEG-rHuMGDF established in cancer patients

Nov. 21, 1996

Solvay and TheraTech end HRT collaboration

Nov. 21, 1996

Arris/Merck & Co. osteoporosis collaboration

Nov. 21, 1996

French market introduction for Fractal

Nov. 21, 1996

HRT for preserving bone density in postmenopausal women

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...